Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Cash & Equivalents (2010 - 2025)

Siga Technologies' (SIGA) quarterly Cash & Equivalents came in at $155.0 million in Q4 2025, little changed on a YoY basis from $155.4 million in Q4 2024, and down 9.88% quarter-over-quarter from $172.0 million in Q3 2025.

Analysis

Siga Technologies (SIGA) Cash & Equivalents (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Cash & Equivalents for 16 consecutive years, with $155.0 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents changed 0.28% year-over-year to $155.0 million; the trailing twelve-month figure through Dec 2025 stood at $155.0 million (changed 0.28% YoY), and the FY2025 full-year result was $155.0 million, changed 0.28% from the prior year.
  • Cash & Equivalents slipped to $155.0 million in Q4 2025 per SIGA's latest filing, from $172.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $182.5 million in Q2 2025 and bottomed at $71.1 million in Q3 2023.
  • Historically, Cash & Equivalents has averaged $123.4 million across 5 years, with a median of $112.1 million in 2022.
  • The sharpest annual moves came in 2021 and 2023: Cash & Equivalents jumped 85.59% in 2021, then plunged 35.2% in 2023.
  • Over 5 years, Cash & Equivalents stood at $103.1 million in 2021, then declined by 4.22% to $98.8 million in 2022, then soared by 51.98% to $150.1 million in 2023, then increased by 3.5% to $155.4 million in 2024, then retreated by 0.28% to $155.0 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $155.0 million, $172.0 million, and $182.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 20.42 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 6.57 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 6.85 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 7.62 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 976.00 Mn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 7.38 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 815.44 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 3.98 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 1.80 Bn
10 Siga Technologies 220.19 Mn 65.22 Mn - 154.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 154.97 Mn
Sep 30, 2025 171.96 Mn
Jun 30, 2025 182.46 Mn
Mar 31, 2025 162.27 Mn
Dec 31, 2024 155.40 Mn
Sep 30, 2024 99.27 Mn
Jun 30, 2024 106.95 Mn
Mar 31, 2024 143.87 Mn
Dec 31, 2023 150.15 Mn
Sep 30, 2023 71.11 Mn
Jun 30, 2023 76.21 Mn
Mar 31, 2023 115.68 Mn
Dec 31, 2022 98.79 Mn
Sep 30, 2022 109.75 Mn
Jun 30, 2022 114.53 Mn
Mar 31, 2022 153.26 Mn
Dec 31, 2021 103.14 Mn
Sep 30, 2021 92.82 Mn
Jun 30, 2021 98.49 Mn
Mar 31, 2021 106.53 Mn